14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.49 $7.64 Tuesday, 23rd Apr 2024 FATE stock ended at $4.54. This is 5.02% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 11.93% from a day low at $4.49 to a day high of $5.02.
90 days $4.40 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Mar 18, 2024 $7.49 $7.50 $6.96 $7.04 1 764 370
Mar 15, 2024 $7.24 $7.70 $7.21 $7.49 9 650 759
Mar 14, 2024 $7.62 $7.67 $6.91 $7.23 2 217 756
Mar 13, 2024 $7.60 $7.98 $7.40 $7.64 1 797 501
Mar 12, 2024 $7.83 $8.27 $7.65 $7.66 2 727 257
Mar 11, 2024 $8.15 $8.44 $7.86 $7.89 1 806 236
Mar 08, 2024 $8.52 $8.74 $7.82 $8.12 2 440 089
Mar 07, 2024 $8.02 $8.83 $7.94 $8.35 3 875 099
Mar 06, 2024 $7.16 $8.07 $7.01 $7.98 2 555 878
Mar 05, 2024 $7.02 $7.07 $6.81 $6.93 1 538 470
Mar 04, 2024 $7.77 $7.90 $7.05 $7.08 1 609 067
Mar 01, 2024 $7.16 $7.80 $7.16 $7.74 1 822 848
Feb 29, 2024 $7.43 $7.60 $7.06 $7.09 1 815 025
Feb 28, 2024 $7.36 $8.17 $7.07 $7.14 3 450 520
Feb 27, 2024 $7.56 $8.62 $6.71 $7.46 4 062 728
Feb 26, 2024 $6.96 $7.17 $6.67 $6.95 2 086 850
Feb 23, 2024 $6.86 $7.11 $6.75 $6.96 1 507 544
Feb 22, 2024 $6.92 $7.04 $6.62 $6.88 1 921 708
Feb 21, 2024 $7.03 $7.09 $6.47 $6.83 1 635 594
Feb 20, 2024 $7.36 $7.60 $6.79 $7.06 2 723 240
Feb 16, 2024 $7.00 $7.73 $6.87 $7.56 2 532 023
Feb 15, 2024 $6.63 $7.20 $6.52 $7.08 2 872 440
Feb 14, 2024 $6.58 $6.60 $6.21 $6.49 1 309 115
Feb 13, 2024 $6.39 $6.54 $6.17 $6.39 1 930 430
Feb 12, 2024 $6.31 $6.88 $6.19 $6.86 2 497 618
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT